SLC2A1 and neoplasm: In tumor-like, lactate-rich hypoxic environments, the stabilization of lactylated HIF-1α may potentiate glycolytic and prosurvival gene programs (e.g., VEGF and GLUT1), thereby enhancing metabolic adaptation, cell survival, and chemoresistance [43, 44].